![](/img/cover-not-exists.png)
Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β 3 -Adrenoceptor Agonist, in Japanese Patients with Overactive Bladder
YAMAGUCHI, Osamu, IKEDA, Yasushi, OHKAWA, SumitoLanguage:
english
Journal:
LUTS: Lower Urinary Tract Symptoms
DOI:
10.1111/luts.12107
Date:
June, 2015
File:
PDF, 1.14 MB
english, 2015